Curevo has set its sights on competing with GSK’s shingles vaccine dominance by securing $110m and securing a former executive from the UK big pharma to advance its candidate amezosvatein.

Our preclinical studies in animal models have demonstrated promising results in reducing obesity and fatty liver disease.

Contract Development and Manufacturing Organizations (CDMOs) enhance drug discovery by providing essential services that reduce costs and accelerate production.

August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new ...

Serving the pharmaceutical, bioscience and healthcare industry, IAG Cargo’s Constant Climate product is a cutting-edge cold chain solution designed ...

Croda International Plc (Yorkshire, U.K.;   today announces the opening of a pioneering new lipids manufacturing facility in Lamar, ...

If left unchecked, the power of PBMs and their complex relationships within the American healthcare system could lead to higher drug costs and diminished returns.

Shares of vaccine-maker Moderna MRNA closed at $34.71 on Monday, close to their 52-week low of $29.25. Moderna is facing several headwinds, including the declining COVID-19 vaccine and the soft sales ...

The global industry was valued at US$ 527.5 Mn in 2024 and is projected to exceed US$ 771.0 Mn by 2035, growing at a CAGR of ...

In recent years, the rapid advancement of artificial intelligence (AI) has ushered in a transformative era in medical and biological research.

The general mood among these heavyweight investors is divided, with 63% leaning bullish and 36% bearish. Among these notable ...